Key result
Percutaneous transluminal coronary angioplasty had a 36% lower 1-year cost than coronary bypass surgery (13,625 vs 21,363 Dfl), despite a higher 1-year reintervention rate.
Why the study?
Does PTCA compared to CABG result in lower 1-year costs in patients with angina pectoris?
Observational
Does PTCA compared to CABG result in lower 1-year costs in patients with angina pectoris?
PTCA has lower initial and 1-year costs compared to CABG, but higher reintervention rates may equalize costs over a longer time span.
Answers are grounded in this paper and cite their sources.
PTCA was associated with lower 1-year costs than CABG; leaves open long-term equivalence pending RCTs with extended follow-up.
To determine the costs of a procedure, the total costs of the department that provides the service must be considered and, in addition, the direct cost of the specific procedure. Applying this principle to the cost accounting of angioplasty and bypass surgery results in a direct, i.e. procedural, cost, including the initial hospital stay, of respectively 8694 Dfl and 20,987 Dfl. A review of the follow-up data for the first year after the original intervention revealed a 2% reintervention rate for bypass surgery, while this percentage was 29% for angioplasty. Adding the first year costs involved with reinterventions to the procedural costs results in a 1-year cost of angioplasty and bypass operation of 13,625 Dfl and 21,363 Dfl, respectively. It is concluded that because of reinterventions in the first year, a mark up of 57% on the procedural cost of angioplasty must be added to cover 1-year costs, while for bypass surgery this is only 1%. Nevertheless, the 1-year cost for angioplasty is still 36% less than for bypass surgery. As reinterventions after PTCA may stay considerably higher than for CABG for several years, the mark-up percentages will be substantially higher for longer time spans. This may tend to equalize the total costs of PTCA and CABG over time spans of perhaps 5-8 years. Sufficient data are not available to verify this statement. Clinicians must realize that choosing the most appropriate procedure is not only a matter of medical assessment but also a matter of cost effectiveness. CABG can be seen as an 'investment decision' while PTCA tends to become a decision with characteristics of 'maintenance planning'!
No takes yet. Share an insight, caveat, or question.
BRAND et al. (1990) conducted an observational in Angina pectoris. Percutaneous transluminal coronary angioplasty (PTCA) vs. Coronary bypass surgery (CABG) was evaluated on 1-year cost (procedural plus reinterventions in Dfl). Percutaneous transluminal coronary angioplasty had a 36% lower 1-year cost than coronary bypass surgery (13,625 vs 21,363 Dfl), despite a higher 1-year reintervention rate.
Synapse has enriched 10 related papers. Consider them for comparative context: